Agila Specialities Inc. et al. vs. Cubist Pharmaceuticals, Inc. et al.
Explore the PTAB proceeding IPR2015-00143 filed by Agila Specialities Inc. et al. on 2014-10-23. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2015-00143
Filing Date
2014-10-23
Accorded Filing Date
2014-10-23
Institution Decision Date
2015-04-28
Last Modified Date
2022-10-10
Proceeding Type
IPR
Termination Date
2015-04-28
Trial Status
Institution Denied
Parties & Counsel
Petitioner
Agila Specialities Inc. et al.
Represented By
Munson, Peteret alPatent Owner / Respondent
Cubist Pharmaceuticals, Inc. et al.
Represented By
Whelan, Emilyet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Institution Denied
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 34398 | Mary Morry | +1 732-594-1935 |
| 36036 | John Todaro | +1 732-594-0125 |
| 36436 | Sylvia Ayler | +1 732-594-4909 |
| 36502 | Catherine Fitch | +1 732-594-4283 |
| 42068 | Dianne Pecoraro | +1 732-594-1249 |
| 42452 | Anna Cocuzzo | +1 -- |
| 42876 | Eric Meade | +1 732-594-1045 |
| 43039 | John Reilly | +1 732-594-6914 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 8 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 8,058,238 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,129,342 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,604,164 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,853,357 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 9,358,267 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 17,717,000 P | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 6,696,412 B1 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2005000974 | US Continuation / Sibling | View Official Patent → |
Fresenius Kabi USA LLC v. Cubist Pharmaceuticals LLC et al.
Fresenius Kabi USA LLC v. Cubist Pharmaceuticals LLC
Fresenius Kabi USA LLC v. Cubist Pharmaceuticals LLC
Fresenius Kabi USA LLC v. Cubist Pharmaceuticals LLC
Agila Specialties Inc. et al. v. Cubist Pharmaceuticals, Inc. et al.
Agila Specialities Inc. et al. v. Cubist Pharmaceuticals, Inc. et al.
Agila Specialities Inc. et al. v. Cubist Pharmaceuticals, Inc. et al.
Agila Specialities Inc. et al. v. Cubist Pharmaceuticals, Inc. et al.
Cubist Pharmaceuticals LLC v. Crane Pharmaceuticals LLC
Cubist Pharmaceuticals LLC v. Dr. Reddys Laboratories, Ltd.
Cubist Pharmaceuticals LLC v. Actavis LLC
Cubist Pharmaceuticals LLC v. Sagent Pharmaceuticals, Inc.
Cubist Pharmaceuticals Inc. v. Fresenius Kabi USA LLC
Cubist Pharmaceuticals LLC. v. Mylan Laboratories Limited
Cubist Pharmaceuticals Inc. v. Hospira Inc.